Early i-IFTA: Associated factors and impact on graft outcome.

PubMed 2026 Open access

Read full text
Authors: Antoine Taillandier, Tristan de Nattes, Damien Sizaret, Philippe Gatault, C. Bonenfant, Claire Kizlik, Lucie Maigret, Marie‐Christine Machet, Marion Rabant, Juliette Gueguen, Elodie Miquelestorena‐Standley
DOI: 10.14670/hh-25-005
Cited by: 0

Abstract

=0.060). I-IFTA0/1 and 2/3 presented comparable one-year graft outcomes, including donor-specific antibodies (DSA), rejection occurrence, and graft function. In conclusion, early i-IFTA is an ambiguous and non-specific lesion that can be associated with ischemia/reperfusion injury, early BK nephropathy, or rejection.

Fields of Study & Subjects

Electrospun Nanofibers in Biomedical Applications

Publication details

Journal / source
PubMed
Volume
41
Issue
4
Pages
617–627
Publication date
1 April 2026
Language
EN